Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Source filing unavailable
Q4 2014 · —
Revenue$4.49B$4.49B+29.6% vs Q4 2013 Net income—
EPS Diluted$1.49$1.49+62.0% vs Q4 2013 Gross Profit$2,091,900,000+41.2% Operating Incomederived$639,100,000+40.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$797,000,000+25.7% Margins · derivedGross margin46.6%+3.8 pt vs Q4 2013
Operating margin14.2%+1.1 pt vs Q4 2013